Europe Surgical Robots Market is expected to reach US$ 5,059.11 million by 2028
Report : Europe Surgical Robots Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Instruments & Accessories, Robotic Systems, and Services), Application (Urological Surgery, Orthopedic Surgery, General Surgery, Gynecological Surgery, Cardiothoracic Surgery, Neurosurgery, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others)
At 14.3% CAGR, the Europe Surgical Robots Market is speculated to be worth US$ 5,059.11 million by 2028, says Business Market Insights
According to Business Market Insights' research, the Europe surgical robots market was valued at US$ 2,267.95 million in 2022 and is expected to reach US$ 5,059.11 million by 2028, registering an annual growth rate of 14.3% from 2022 to 2028. Rising number of surgical procedures and increasing number of product launches and approvals
Increasing incidences of chronic diseases, gynecological diseases, orthopedic diseases, urological diseases, neurological diseases, cardiothoracic diseases, etc. are anticipated to generate growth opportunities for Robots-assisted surgery systems, owing to the several advantages associated with them, such as the facilitation of precise, tremor-free surgery and benefits of minimally invasive methods. Moreover, CE mark approval is for urological and gynecological procedures, which make up about half of all Robotic procedures performed nowadays. The adoption of Robotic telesurgery is increasing owing to the rising incidences of cholecystectomy, which is creating growth opportunities for the development of Surgical Robots such as the Puma 560, a Robots that was first used in 1985; it carried out neurosurgical biopsies and the transurethral resection of the prostate. According to the National Air and Space Administration (NASA) Ames Research Center, telesurgery is one of the most intensive research areas, which has further resulted in the advancement opportunities for surgical Robots. Intuitive Surgical Inc has been developing active medical Robots to perform surgeries. For instance, the da Vinci surgical system, an advanced master-slave system, has multiple–slave systems with several Robotic arms or manipulators controlled remotely by a surgeon from a console. These systems use miniaturized operating arms, unlike the one-centimeter surgical arms of the Puma 560, avoiding the need to retract the sides of the incision. The Endo-Wrist features of the operating arms in da vinci also provide seven degrees of movement freedom. Further, newer systems use ergonomically superior open consoles rather than the closed ones of the da Vinci system. Other market opportunities, such as laparo-endoscopic single-site surgery (LESS) Robots, are also being developed by leading market players. The laparo-endoscopic single-site surgery (LESS) Robots insert the camera and multiple instruments through a single incision, preferably the umbilical, in which case there is no scar. Additionally, smaller systems such as the SurgiBot-SPIDER (Single-Port Instrument Delivery Extended Research) systems are being developed, which are significantly less expensive and have not yet gained FDA approval. The Minimally Invasive Neurosurgical Intracranial Robots (MINIR) is one of the newer Robots used to remove brain tumors, based on a CTSM with SMA actuators. The flex system uses cables with variable tension to modulate the flexibility of the endoscope, allowing many procedures to be carried out while using only a fraction of the space required by the da Vinci system. The above-mentioned factors are creating growth opportunities for the surgical robots market during the forecast period.
On the contrary, high price of surgical procedures and Installation hurdles the growth of Europe surgical robots market.
Based on component, the Europe surgical robots market is categorized into instruments & accessories, robotic systems, and services. The instruments & accessories segment held 52.4% market share in 2022, amassing US$ 1,188.84 million. It is projected to garner US$ 2,755.25 million by 2028 to expand at 15.0% CAGR during 2022–2028.
Based on application, the Europe surgical robots market is bifurcated into urological surgery, orthopedic surgery, general surgery, gynecological surgery, cardiothoracic surgery, neurosurgery, and others. The urological surgery segment held 23.1% market share in 2022, amassing US$ 523.20 million. It is projected to garner US$ 1,218.86 million by 2028 to expand at 15.1% CAGR during 2022–2028
Based on end user, the Europe surgical robots market is categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment held 65.4% market share in 2022, amassing US$ 1,483.66 million. It is projected to garner US$ 3,274.16 million by 2028 to expand at 14.1% CAGR during 2022–2028.
Based on country, the Europe surgical robots market has been categorized into the Germany, UK, France, Italy, Spain, and Rest of Europe. Our regional analysis states that Germany captured 24.8% market share in 2022. It was assessed at US$ 561.42 million in 2022 and is likely to hit US$ 1,323.82 million by 2028, exhibiting a CAGR of 15.4% during the forecast period.
Key players dominating the Europe surgical robots market are Intuitive Surgical; Smith+Nephew; Johnson & Johnson Services, Inc.; Stryker; THINK Surgical; Zimmer Biomet; Medtronic; Siemens Healthineers AG; Asensus Surgical, Inc.; and Renishaw plc among others.
In Jun 2022, Stryker Wins FDA Clearance for Q Guidance System for Spine Applications.
In Jul 2022, Zimmer Biomet and Hospital for Special Surgery (HSS) Announce Creation of the HSS/Zimmer Biomet Innovation Center for Artificial Intelligence in Robotic Joint Replacement.
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com